• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减重手术术后早期体重减轻的临床意义:一项叙述性综述

Clinical Significance of Early Postoperative Weight Loss in Bariatric Surgery: A Narrative Review.

作者信息

Kim Su-Mi

机构信息

Department of Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Korea.

出版信息

J Metab Bariatr Surg. 2025 Aug;14(2):139-149. doi: 10.17476/jmbs.2025.14.2.139. Epub 2025 Aug 22.

DOI:10.17476/jmbs.2025.14.2.139
PMID:40917199
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12411145/
Abstract

Early postoperative weight loss (EWL) after bariatric surgery is a critical as a powerful predictor of long-term weight loss and metabolic outcomes. This narrative review shows evidence from recent studies examining the biological, behavioral, and clinical implications of EWL in patients undergoing various bariatric procedures. We discuss the hormonal and metabolic adaptations that occur in the first months after surgery, the psychosocial and behavioral factors influencing postoperative outcomes, and how early weight loss can guide individualized management. We further conduct the clinical pathways that integrate EWL monitoring into routine postoperative care. The goal is to encourage standardization in EWL measurement and its integration into multidisciplinary bariatric management to improve patient postoperative outcomes.

摘要

减重手术后的早期体重减轻(EWL)至关重要,因为它是长期体重减轻和代谢结果的有力预测指标。本叙述性综述展示了近期研究的证据,这些研究探讨了EWL在接受各种减重手术患者中的生物学、行为学和临床意义。我们讨论了术后头几个月发生的激素和代谢适应、影响术后结果的心理社会和行为因素,以及早期体重减轻如何指导个体化管理。我们还进一步探讨了将EWL监测纳入常规术后护理的临床路径。目标是鼓励EWL测量的标准化及其在多学科减重管理中的整合,以改善患者术后结果。

相似文献

1
Clinical Significance of Early Postoperative Weight Loss in Bariatric Surgery: A Narrative Review.减重手术术后早期体重减轻的临床意义:一项叙述性综述
J Metab Bariatr Surg. 2025 Aug;14(2):139-149. doi: 10.17476/jmbs.2025.14.2.139. Epub 2025 Aug 22.
2
Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature.减重手术后的长期结果:可调胃束带术 15 年随访结果及减重手术文献的系统评价
Ann Surg. 2013 Jan;257(1):87-94. doi: 10.1097/SLA.0b013e31827b6c02.
3
Position statement and guidelines about Endoscopic Sleeve Gastroplasty (ESG) also known as "Endo-sleeve".关于内镜下袖状胃成形术(ESG,也称为“内镜袖套术”)的立场声明和指南。
J Visc Surg. 2025 Feb;162(1):71-78. doi: 10.1016/j.jviscsurg.2024.12.003. Epub 2025 Jan 9.
4
Sex difference in the safety and efficacy of bariatric procedures: a systematic review and meta-analysis.减重手术安全性和疗效的性别差异:系统评价和荟萃分析。
Surg Obes Relat Dis. 2022 Jul;18(7):983-996. doi: 10.1016/j.soard.2022.03.022. Epub 2022 Apr 20.
5
The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.减肥手术治疗肥胖症的临床疗效和成本效益:一项系统评价与经济评估
Health Technol Assess. 2009 Sep;13(41):1-190, 215-357, iii-iv. doi: 10.3310/hta13410.
6
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
7
Preoperative comorbidities as a predictor of EBWL after bariatric surgery: a retrospective cohort study.术前合并症是减重手术后 EBWL 的预测因子:一项回顾性队列研究。
Surg Endosc. 2024 May;38(5):2770-2776. doi: 10.1007/s00464-024-10785-z. Epub 2024 Apr 5.
8
Rehabilitation following surgery for lumbar spinal stenosis.腰椎管狭窄症手术后的康复
Cochrane Database Syst Rev. 2013 Dec 9;2013(12):CD009644. doi: 10.1002/14651858.CD009644.pub2.
9
Nurse-led intervention for the management of bariatric surgery patients: A systematic review.护士主导的干预措施在肥胖症手术患者管理中的应用:系统评价。
Obes Rev. 2023 Nov;24(11):e13614. doi: 10.1111/obr.13614. Epub 2023 Aug 22.
10
Does Augmenting Irradiated Autografts With Free Vascularized Fibula Graft in Patients With Bone Loss From a Malignant Tumor Achieve Union, Function, and Complication Rate Comparably to Patients Without Bone Loss and Augmentation When Reconstructing Intercalary Resections in the Lower Extremity?对于因恶性肿瘤导致骨缺损的患者,在重建下肢节段性切除时,采用带血管游离腓骨移植来增强照射后的自体骨移植,其骨愈合、功能及并发症发生率与无骨缺损且未进行增强的患者相比是否相当?
Clin Orthop Relat Res. 2025 Jun 26. doi: 10.1097/CORR.0000000000003599.

本文引用的文献

1
Long-Term Follow-Up After Bariatric Surgery: Key to Successful Outcomes in Obesity Management.减肥手术后的长期随访:肥胖管理成功结果的关键
Nutrients. 2024 Dec 21;16(24):4399. doi: 10.3390/nu16244399.
2
Liraglutide for the Treatment of Weight Regain After Bariatric Surgery: A Systematic Review and Meta-analysis.利拉鲁肽治疗减重手术后体重反弹:系统评价和荟萃分析。
Obes Surg. 2024 Aug;34(8):2844-2853. doi: 10.1007/s11695-024-07384-1. Epub 2024 Jul 10.
3
Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis.《减重手术后患者应用胰高血糖素样肽-1 受体激动剂:系统评价和荟萃分析》
Obes Surg. 2024 May;34(5):1653-1664. doi: 10.1007/s11695-024-07175-8. Epub 2024 Mar 19.
4
Prospective evaluation of transoral outlet reduction (TORe) after Roux-en-Y gastric bypass (RYGB) failure.Roux-en-Y胃旁路术(RYGB)失败后经口缩小出口(TORe)的前瞻性评估。
Surg Endosc. 2024 Mar;38(3):1454-1464. doi: 10.1007/s00464-023-10650-5. Epub 2024 Jan 12.
5
Safety and Efficacy of Liraglutide, 3.0 mg, Once Daily vs Placebo in Patients With Poor Weight Loss Following Metabolic Surgery: The BARI-OPTIMISE Randomized Clinical Trial.利拉鲁肽 3.0 毫克每日一次与安慰剂治疗代谢手术后体重减轻不佳患者的安全性和疗效:BARI-OPTIMISE 随机临床试验。
JAMA Surg. 2023 Oct 1;158(10):1003-1011. doi: 10.1001/jamasurg.2023.2930.
6
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.利拉鲁肽和司美格鲁肽作为减重手术后体重反弹的治疗药物的疗效:一项回顾性观察研究。
Obes Surg. 2023 Apr;33(4):1017-1025. doi: 10.1007/s11695-023-06484-8. Epub 2023 Feb 11.
7
Weight Regain After Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment.减重手术后体重反弹:问题范围、原因、预防和治疗。
Curr Diab Rep. 2023 Mar;23(3):31-42. doi: 10.1007/s11892-023-01498-z. Epub 2023 Feb 8.
8
Pharmacologic management of weight regain following bariatric surgery.减重手术后体重反弹的药物治疗管理。
Front Endocrinol (Lausanne). 2023 Jan 9;13:1043595. doi: 10.3389/fendo.2022.1043595. eCollection 2022.
9
Comment on: Long-term outcome after biliopancreatic diversion with duodenal switch: a single-center experience with up to 20 years' follow-up.关于《胆胰转流十二指肠转位术的长期疗效:一项长达20年随访的单中心经验》的评论
Surg Obes Relat Dis. 2023 Feb;19(2):90-91. doi: 10.1016/j.soard.2022.11.007. Epub 2022 Nov 17.
10
Early Postoperative Weight Loss Predicts Weight Loss up to 5 Years After Roux-En-Y Gastric Bypass, Banded Roux-En-Y Gastric Bypass, and Sleeve Gastrectomy.术后早期体重减轻可预测 Roux-en-Y 胃旁路术、带袖套的 Roux-en-Y 胃旁路术和袖状胃切除术 5 年后的体重减轻。
Obes Surg. 2022 Sep;32(9):2891-2902. doi: 10.1007/s11695-022-06166-x. Epub 2022 Jul 16.